Acute Megakaryoblastic leukemia in Down syndrome

被引:18
|
作者
Hitzler, Johann K. [1 ]
机构
[1] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada
关键词
down syndrome; GATA; 1; mutations;
D O I
10.1002/pbc.21353
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Children with Down syndrome (DS) have a 10- to 20-fold increased risk of developing acute leukemia. An estimated 10% of newborns with DS develop Transient Myeloproliferative Disease (TMD) or Transient Leukemia (TL), a clonal accumulation of megakaryoblasts that resolves spontaneously within months. Acute megakaryoblastic leukemia (AMKL) develops in approximately 20% of cases of TMD/TL by 4 years of age. Both the blasts of AMKL and TMD/TL in DS harbor somatic mutations of GATA1, an essential transcriptional regulator of megakaryocytic differentiation. The distinct phenotypes of megakaryoblastic leukemia in DS are a unique biological model of the incremental process of leukeimic transformation.
引用
收藏
页码:1066 / 1069
页数:4
相关论文
共 50 条
  • [31] Hematologic Malignancies in Children with Down Syndrome: Transient Myeloproliferative Disease and Acute Megakaryoblastic Leukemia
    Atik, Tahir
    Sivis, Zuhal Onder
    Karadas, Nihal
    Rashnonejad, Afrooz
    Atikan, Basak Yildiz
    Karapinar, Deniz Yilmaz
    Vardar, Fadil
    Cogulu, Ozgur
    Ozkinay, Ferda
    [J]. JOURNAL OF PEDIATRIC RESEARCH, 2015, 2 (01) : 46 - 48
  • [32] Distinctive Multidrug Sensitivity and Outcome of Acute Erythroblastic and Megakaryoblastic Leukemia in Children With Down Syndrome
    Sayuri Yamada
    Teruaki Hongo
    Shuichi Okada
    Chieko Watanabe
    Yuji Fujii
    Hiroki Hori
    Makoto Yazaki
    Ryoji Hanada
    Yasuo Horikoshi
    [J]. International Journal of Hematology, 2001, 74 : 428 - 436
  • [33] ACUTE MEGAKARYOBLASTIC LEUKEMIA AND KLINEFELTERS-SYNDROME
    PHEBUS, CK
    BERG, SL
    [J]. AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1986, 8 (03): : 260 - 262
  • [34] Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome
    J H Klusmann
    D Reinhardt
    H Hasle
    G J Kaspers
    U Creutzig
    K Hahlen
    M M van den Heuvel-Eibrink
    C M Zwaan
    [J]. Leukemia, 2007, 21 : 1584 - 1587
  • [35] A New Entity?: Distinctive Immunophenotype in Non-Down Syndrome Pediatric Acute Megakaryoblastic Leukemia
    Wang, L.
    Levenson, B.
    Karandikar, N. J.
    Emmons, J.
    [J]. MODERN PATHOLOGY, 2013, 26 : 366A - 366A
  • [36] Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings
    Rodrigues, Eliane Ferreira
    da Costa, Elaine Sobral
    Land, Marcelo Gerardin
    Diamond, Hilda Rachel
    Ornellas, Maria Helena
    Abdelhay, Eliana
    Fernandez, Teresa de Souza
    [J]. CANCER GENETICS AND CYTOGENETICS, 2009, 188 (01) : 54 - 56
  • [37] Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down’s syndrome
    SK Ma
    ACW Lee
    TSK Wan
    CK Lam
    LC Chan
    [J]. Leukemia, 1999, 13 : 491 - 492
  • [38] ACUTE MEGAKARYOBLASTIC LEUKEMIA FOLLOWING TRANSIENT MYELOPROLIFERATIVE DISORDER IN A PATIENT WITHOUT DOWN-SYNDROME
    BRISSETTE, MD
    DUVALARNOULD, BJ
    GORDON, BG
    COTELINGAM, JD
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (04) : 316 - 319
  • [39] Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome
    Ma, SK
    Lee, ACW
    Wan, TSK
    Lam, CK
    Chan, LC
    [J]. LEUKEMIA, 1999, 13 (03) : 491 - 492
  • [40] Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome
    Klusmann, J. H.
    Reinhardt, D.
    Hasle, H.
    Kaspers, G. J.
    Creutzig, U.
    Hahlen, K.
    Van den Heuvel-Eibrink, M. M.
    Zwaan, C. M.
    [J]. LEUKEMIA, 2007, 21 (07) : 1584 - 1587